Case-Based Roundtable Meetings Spotlight: June 2022

Chao Discusses Stratifying and Treating Patients With Graft-Vs-Host Disease

June 27, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Nelson Jen An Chao, MD, discussed risk management and treatment of patients with steroid-refractory acute graft-versus-host-disease as well as chronic graft-versus-host disease.

Lee and McGregor Discuss Methods to Integrate New Approaches in RCC Treatment

June 25, 2022

Clinical Articles

During a Targeted Oncology case-based event, Chung-Han Lee, MD, PhD, and Bradley A. McGregor, MD, discussed the case of a patient with recurrent metastatic renal cell carcinoma and that of a patient at risk of recurrence following resection.

Finn Reviews Options and Dosing for a Patient With Unresectable HCC

June 21, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Richard S. Finn, MD, discussed the case of a patient with hepatocellular cancer with a medical history of Crohn disease, cirrhosis, and variceal bleeding.

Evaluating First-Line Treatment Options for Metastatic ccRCC

June 19, 2022

Clinical Articles

During a Targeted Oncology case-based roundtable event, Chandler Park, MD, discussed the preferred first-line treatment options including tyrosine kinase inhibitor/immunotherapy combinations for metastatic clear cell renal cell carcinoma.